Machine learning developed an immune evasion signature for predicting prognosis and immunotherapy benefits in lung adenocarcinoma

ABSTRACT:

SUBMITTER: Ding D 

PROVIDER: S-EPMC12222150 | biostudies-literature | 2025 Jan

REPOSITORIES: biostudies-literature